Exploring how aging brain cells affect Alzheimer's disease progression

Investigating the Impact of Novel Senescent Microglia in Alzheimer's Disease Progression

NIH-funded research Mayo Clinic Rochester · NIH-10883863

This study is looking at a special type of brain cell that might make Alzheimer's disease worse, and by figuring out how to remove these cells in mice, researchers hope to find new ways to help people with Alzheimer's feel better.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionMayo Clinic Rochester NIH-funded
Lab location1 site (Rochester, United States)
Project IDNIH-10883863 on NIH RePORTER

What this research studies

This research investigates the role of a specific type of brain cell, known as senescent microglia, in the progression of Alzheimer's disease. By using advanced techniques to analyze these cells, the researchers aim to understand how they contribute to the disease and whether removing them can slow its progression. The study involves a novel mouse model that allows for the targeted elimination of these cells, providing insights into potential new treatments for Alzheimer's. Patients may benefit from findings that could lead to innovative therapeutic strategies.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk of developing it.

Not a fit: Patients with other forms of dementia unrelated to Alzheimer's may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic approaches that slow or halt the progression of Alzheimer's disease.

How similar studies have performed: Previous research has shown promise in targeting microglial cells for therapeutic purposes, suggesting potential success for this novel approach.

Where this research is happening

Rochester, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.